Mandaviya interacts with representatives of private medical colleges

Seeks partnership between government and private medical colleges for providing superior medical education

PharmaEssentia sets up a new R&D facility in the Boston Area

The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation

Matt Honan joins Emmes as VP & head of corporate development

Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach

IIT Kanpur and Apollo Hospitals join hands for research collaboration

The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology

USFDA grants appeal for Ardelyx's XPHOZAH

Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism

Cipla EU to invest € 15 million in Ethris

Cipla and Ethris partner for the development of mRNA-based therapies

Pfizer announces positive topline results from Phase 3 study of Hemophilia B gene therapy candidate

World's first intranasal vaccine iNCOVACC will be rolled out in the fourth week of January

The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics

GeneQuantum and WuXi XDC enter into strategic cooperation to empower innovative bioconjugates development

Lupin receives USFDA approval for Brivaracetam Tablets